Breast Cancer · IORTAgility TestMarch 3, 2016 · Long Test Content 2testMore in Breast CancerRadiotherapyActinium Pharmaceuticals Initiates RADIANZ Imaging Study to Expand ATNM-400 DevelopmentNovember 11, 2026RadiotherapyActinium Pharmaceuticals to Present Preclinical Efficacy of ATNM-400 at SABCS 2026November 6, 2026Industry NewsASTRO 2026 | Study Highlights Lower Adherence to Endocrine Therapy Post-Lumpectomy When Radiation is ExcludedSeptember 29, 2026
RadiotherapyActinium Pharmaceuticals Initiates RADIANZ Imaging Study to Expand ATNM-400 DevelopmentNovember 11, 2026
RadiotherapyActinium Pharmaceuticals to Present Preclinical Efficacy of ATNM-400 at SABCS 2026November 6, 2026
Industry NewsASTRO 2026 | Study Highlights Lower Adherence to Endocrine Therapy Post-Lumpectomy When Radiation is ExcludedSeptember 29, 2026